Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Submitted by
admin
on April 9, 2013 - 10:45am
Source:
Yahoo/Fly on the Wall
News Tags:
sofosbuvir
Gilead
hepatitis C
Headline:
Gilead submits NDA to FDA for sofosbuvir for the treatment of HCV
Do Not Allow Advertisers to Use My Personal information
